Resources

This page contains links to more information and resources about residential aged care funding reforms.

This guide outlines the categories of care workers that can deliver care minutes, the activities that can qualify as care minutes, the care targets for services and how these are calculated, reporting obligations, and the forthcoming Star Ratings system.

This guide explains how Aged Care Assessment Teams (ACAT) assessors and delegates should enter and manage Short-Term Restorative Care (STRC) details in the My Aged Care assessor portal.

This guide helps Regional Assessment Services (RAS) refer older Australians for service recommendations made in the client’s support plan, based on the client’s preferred service provider in the My Aged Care assessor portal.

This guide helps Aged Care Assessment Teams (ACAT) refer older Australians to aged care services in the My Aged Care assessor portal, including the Commonwealth Home Support Programme and Multi-Purpose Services.

This guide gives people who use the My Aged Care assessor portal an overview of the portal and instructions on how to use it.

This is the application guidelines and application form for the Continence Aids Payment Scheme (CAPS).

These spreadsheets provide 2022 childhood immunisation coverage data by Primary Health Network (PHN), for all children and Aboriginal and Torres Strait Islander children.

These spreadsheets provide 2020 childhood immunisation coverage data by Primary Health Network (PHN), for all children and Aboriginal and Torres Strait Islander children.

These explanatory notes detail the quarterly reporting requirements for food and nutrition.

These guiding principles aim to promote the quality use of medicines when patients move between different health care settings and health care providers.

These guiding principles aim to promote the quality use of medicines and medication management in the community. They support health and community care service providers supporting older people to manage their medicines in their home and in the community.

These guiding principles aim to promote the quality use of medicines when patients move between different health care settings and health care providers.

These guiding principles aim to promote the quality use of medicines and medication management in the community. They support health and community care service providers supporting older people to manage their medicines in their home and in the community.

These guiding principles promote the safe, quality use of medicines and medication management in your aged care home. They are based on evidence and advice from experts, providers and users of medicines in health and aged care services.

This communique summarises the fifth meeting of the Strengthening Medicare Taskforce, held on 25 November 2022.

This collection contains communiques from the Strengthening Medicare Taskforce.

This presentation, delivered on 24 November 2022, contains an update to Australia's COVID-19 vaccine rollout.

The Australian Public Service (APS) employee census is conducted annually and collects information on attitudes and opinions of APS employees. This highlights report presents results for the Department of Health and Aged Care.

The National COVID-19 Community Protection Framework will help outline what public health measures states and territories might put in place to manage the COVID-19 pandemic.

This publication contains information on aged care providers that have been allocated residential places through the ‘bed-ready’ process.

These resources about Star Ratings are to help residential aged care providers and older Australians understand how they are used to compare the quality of residential aged care.

This fact sheet outlines the Star Ratings system for residential aged care providers.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS II for the first time, or after a break.

These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for mucopolysaccharidosis type II (MPS II) under the Life Saving Drugs Program.